2nd Annual Chronic Kidney Disease Drug Development Summit
Revere Hotel Boston Common, 200 Stuart Street, Boston 02116, United States
06 May 2019 - 08 May 2019Summary
2nd CKD3 Summit focuses exclusively on overcoming challenges limiting the development of more efficacious & disease-modifying drugs against diabetic nephropathy, genetic & glomerular kidney disease.Overview
The 2nd Chronic Kidney Disease Drug Development (CKD3) focuses exclusively on overcoming challenges limiting the development of more efficacious and disease-modifying drugs against diabetic nephropathy, genetic and glomerular kidney disease.
Incorporating insights from 25+ industry leading speakers, this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs.
Join 80+ of your colleagues to accelerate the development of SGLT-2 inhibitors, antagonists of renal fibrosis and more, and advance the clinical validity and commercial viability for next-generation standards of care.More Information »